Creative Planning’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$600K Buy
105,583
+4,159
+4% +$20.3K ﹤0.01% 3059
2026
Q1
$435K Sell
101,424
-6,290
-6% -$35K ﹤0.01% 3135
2025
Q4
$965K Buy
107,714
+38,177
+55% +$236K ﹤0.01% 2314
2025
Q3
$257K Buy
69,537
+30,249
+77% +$82.4K ﹤0.01% 3273
2025
Q2
$76.6K Buy
39,288
+28,585
+267% +$59.5K ﹤0.01% 3463
2025
Q1
$18.8K Buy
10,703
+10,065
+1,578% +$22.9K ﹤0.01% 3407
2024
Q4
$1.7K Sell
638
-12,002
-95% -$30.9K ﹤0.01% 3476
2024
Q3
$28.9K Sell
12,640
-9,537
-43% -$29.1K ﹤0.01% 3131
2024
Q2
$64.8K Buy
+22,177
New +$67.7K ﹤0.01% 2900
2023
Q1
Sell
-19,328
Closed -$37.1K 2730
2022
Q4
$37.1K Buy
19,328
+7,249
+60% +$14.7K ﹤0.01% 2262
2022
Q3
$27K Hold
12,079
﹤0.01% 2168
2022
Q2
$39K Hold
12,079
﹤0.01% 2084
2022
Q1
$64K Hold
12,079
﹤0.01% 2034
2021
Q4
$103K Sell
12,079
-821
-6% -$7.55K ﹤0.01% 1951
2021
Q3
$128K Buy
+12,900
New +$117K ﹤0.01% 1918
2021
Q2
Sell
-12,900
Closed -$135K 2424
2021
Q1
$135K Buy
+12,900
New +$144K ﹤0.01% 2187

Other funds holding NUVB

Creative Planning's NUVB Position: Q2 2026 in Review

Creative Planning increased its Nuvation Bio (NUVB) stake by 4.1% in Q2 2026, buying an estimated $20.3K and bringing the position to 105,583 shares worth $600K. The position accounts for ﹤0.01% of the portfolio, ranked #3059.

Creative Planning first reported a position in NUVB in Q1 2021 and has held it in 16 quarters since. The position peaked at $965K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Creative Planning held 105,583 shares of Nuvation Bio worth $600K as of Q2 2026.
  • Creative Planning bought 4,159 Nuvation Bio shares in Q2 2026, an estimated $20.3K.
  • Nuvation Bio made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3059 holding.
  • Creative Planning first reported a position in Nuvation Bio in Q1 2021 and has held it in 16 quarters since.
  • Creative Planning's Nuvation Bio position peaked at $965K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.